Reesink H - Search Results

1

Viral kinetics in patients with chronic hepatitis C treated with the serine protease inhibitor BILN 2061.

Herrmann E, Zeuzem S, Sarrazin C, Hinrichsen H, Benhamou Y, Manns MP, Reiser M, Reesink H, Calleja JL, Forns X, Steinmann GG, Nehmiz G. Herrmann E, et al. Among authors: reesink h. Antivir Ther. 2006;11(3):371-6. Antivir Ther. 2006. PMID: 16759054 Clinical Trial.

2

Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C.

Reiser M, Hinrichsen H, Benhamou Y, Reesink HW, Wedemeyer H, Avendano C, Riba N, Yong CL, Nehmiz G, Steinmann GG. Reiser M, et al. Among authors: reesink hw. Hepatology. 2005 Apr;41(4):832-5. doi: 10.1002/hep.20612. Hepatology. 2005. PMID: 15732092 Clinical Trial.

3

Ultrasound evaluation of perihepatic lymph nodes during antiviral therapy with the protease inhibitor telaprevir (VX-950) in patients with chronic hepatitis C infection.

Friedrich-Rust M, Forestier N, Sarrazin C, Reesink HW, Herrmann E, Zeuzem S. Friedrich-Rust M, et al. Ultrasound Med Biol. 2007 Sep;33(9):1362-7. doi: 10.1016/j.ultrasmedbio.2007.02.017. Epub 2007 Apr 27. Ultrasound Med Biol. 2007. PMID: 17467151

4

Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir.

Sarrazin C, Kieffer TL, Bartels D, Hanzelka B, Müh U, Welker M, Wincheringer D, Zhou Y, Chu HM, Lin C, Weegink C, Reesink H, Zeuzem S, Kwong AD. Sarrazin C, et al. Among authors: reesink h. Gastroenterology. 2007 May;132(5):1767-77. doi: 10.1053/j.gastro.2007.02.037. Epub 2007 Feb 21. Gastroenterology. 2007. PMID: 17484874 Clinical Trial.

5

Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trial.

Manns M, Reesink H, Berg T, Dusheiko G, Flisiak R, Marcellin P, Moreno C, Lenz O, Meyvisch P, Peeters M, Sekar V, Simmen K, Verloes R. Manns M, et al. Among authors: reesink h. Antivir Ther. 2011;16(7):1021-33. doi: 10.3851/IMP1894. Antivir Ther. 2011. PMID: 22024518 Clinical Trial.

6

HVR-1 heterogeneity during treatment with telaprevir with or without pegylated interferon alfa-2a.

Lange CM, Susser S, Herrmann E, Karey U, Kieffer TL, Kwong AD, Schinkel J, Reesink HW, Zeuzem S, Sarrazin C. Lange CM, et al. Scand J Gastroenterol. 2011 Nov;46(11):1362-8. doi: 10.3109/00365521.2011.605465. Epub 2011 Aug 5. Scand J Gastroenterol. 2011. PMID: 21815864 Clinical Trial.

7

Inflammatory markers neopterin and alanine aminotransferase in HCV patients treated with HCV NS3.4A protease inhibitor telaprevir (VX-950) and/or peginterferon alfa-2a.

Gelderblom HC, Zeuzem S, Weegink CJ, Forestier N, Mcnair L, Purdy S, Dijkgraaf MG, Jansen PL, Reesink HW. Gelderblom HC, et al. Scand J Gastroenterol. 2008;43(9):1122-7. doi: 10.1080/00365520802044210. Scand J Gastroenterol. 2008. PMID: 18609142 Clinical Trial.

8

Evolution of hepatitis C virus quasispecies during repeated treatment with the NS3/4A protease inhibitor telaprevir.

Susser S, Flinders M, Reesink HW, Zeuzem S, Lawyer G, Ghys A, Van Eygen V, Witek J, De Meyer S, Sarrazin C. Susser S, et al. Antimicrob Agents Chemother. 2015 May;59(5):2746-55. doi: 10.1128/AAC.04911-14. Epub 2015 Feb 23. Antimicrob Agents Chemother. 2015. PMID: 25712364 Free PMC article. Clinical Trial.

9

Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study.

Gane EJ, DeJesus E, Janczewska E, George J, Diago M, Da Silva MH, Reesink H, Nikitin I, Hinrichsen H, Bourgeois S, Ferenci P, Shukla U, Kalmeijer R, Lenz O, Fevery B, Corbett C, Beumont M, Jessner W. Gane EJ, et al. Among authors: reesink h. BMC Infect Dis. 2017 Jun 2;17(1):389. doi: 10.1186/s12879-017-2444-3. BMC Infect Dis. 2017. PMID: 28577353 Free PMC article. Clinical Trial.

10

Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment response.

Muir AJ, Poordad FF, McHutchison JG, Shiffman ML, Berg T, Ferenci P, Heathcote EJ, Pawlotsky JM, Zeuzem S, Reesink HW, Dusheiko G, Martin EC, George S, Kauffman RS, Adda N. Muir AJ, et al. Hepatology. 2011 Nov;54(5):1538-46. doi: 10.1002/hep.24549. Hepatology. 2011. PMID: 22045671 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

459 results

Search Page

Filters